| 摘要 |
The invention relates to pharmaceutical compositions for anxiety neuroses and neuroses similar thereto, as well as psychosomatic complications, in particular constitutional anxiety neuroses, which contain a) one or more beta -(p-halogenophenyl)- gamma -aminobutyric acid(s) and b) one or more anxiolytic(s) in combination as active ingredients, expediently together with one or more customary pharmaceutically utilisable formulating agent(s). |
